Filter
1109
Text search:
molecular
testing
Featured
Recommendations
154
New Publications
233
Language
Document type
No document type
540
Guidelines
235
Studies & Reports
180
Manuals
57
Strategic & Response Plan
47
Fact sheets
24
Training Material
12
Situation Updates
9
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
70
Western and Central Europe
41
Global
36
Latin America and the Carribbean
27
Africa
26
Eastern Europe
24
Kenya
23
South Africa
20
Tanzania
18
Ethiopia
17
Brazil
13
East and Southern Africa
13
West and Central Africa
13
Sierra Leone
11
Malawi
11
Russia
11
Uganda
10
Nigeria
9
Rwanda
9
Liberia
8
Philippines
8
Zambia
8
Colombia
8
South–East Asia Region
8
Asia
8
Nepal
7
Mozambique
7
Namibia
7
Peru
7
Zimbabwe
6
Bangladesh
6
Argentina
6
Senegal
5
Congo, Democratic Republic of
5
Germany
5
Indonesia
5
Ukraine
5
Myanmar / Burma
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
USA
4
Ghana
4
Pakistan
4
Syria
4
Angola
4
Guinea-Bissau
3
Cambodia
3
Eswatini/ Swaziland
3
Ecuador
3
Botswana
3
El Salvador
3
Chile
3
Vietnam
3
Spain
3
Guinea
2
Burkina Faso
2
Cameroon
2
South Sudan
2
Lebanon
2
Turkey
2
Bolivia
2
Venezuela
2
Tajikistan
2
Georgia
2
Haiti
1
Somalia
1
Jordan
1
Afghanistan
1
Gambia
1
Benin
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Guatemala
1
Lesotho
1
Mexico
1
Nicaragua
1
Palestine
1
Timor Leste/ East Timor
1
North America
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
328
Clinical Guidelines
163
Pharmacy & Technologies
52
Public Health
44
Key Resources
22
Women & Child Health
14
Capacity Building
4
Toolboxes
TB
250
COVID-19
154
AMR
81
HIV
75
NTDs
60
Rapid Response
58
Ebola
32
Mental Health
25
Planetary Health
23
Pharmacy
20
Zika
19
Refugee
13
Polio
12
NCDs
12
Specific Hazards
8
Caregiver
6
Cholera
5
Natural Hazards
4
Health Financing Toolbox
4
Disability
3
Conflict
3
Global Health Education
2
Barriers to the prompt and effective diagnosis and treatment of malaria exist at both the community and health facility level. Household surveys measure malaria case management at the population level with standard indicators that assess treatment-seeking behavior, access to diagnostic
...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional
...
This document outlines minimum requirements of laboratory testing for COVID-19 and link laboratory testing with surveillance and contact tracing to guide the outbreak response by national health aut
...
Antimicrobial Resistance Surveillance and Research Network | This document contains detail procedures on sample collection, transport, isolation, identification of fungi for the diagnosis of invasive fungal infections and antifungal susceptibility testing
...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the cur
...
Interim Guidance 31 march 2020
WHO has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 from the country of collection to one of the WHO reference laboratories providing confirmatory
...
Aлгоритм лабораторной диагностики и мониторинга лечения туберкулеза легких и туберкулеза с лекарственной устойчивостью на основе применения современных быстрых
...
A survey of prevention, testing and treatment policies and practices
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and
...
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of dat
...
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acut
...
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union
...
La presente publicación describe la evidencia científica disponible sobre la utilidad del uso complementario de pruebas moleculares y de detección de anticuerpos para mejorar el diagnóstico de sospechosos de COVID-19. La utilización complementaria de ambas pruebas podría mejorar la identificac
...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca
...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8
...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular
...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the
...
